Lion TCR

About:

Lion TCR is a clinical-stage biotechnology company.

Website: http://liontcr.com/

Top Investors: Guangzhou Industrial Investment Group, Westlake Venture Partners, Guangzhou Guoju Venture Capital, CSPC NARD Capital, Yashang Capital

Description:

They are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia. For the past decade, they have accumulated expertise covering the entire product development process, ranging from basic research, T cell engineering and development, and preclinical/clinical assessment. Led by industry and academic experts from their base in Singapore, they are dedicated to the commercialization and continued development of their immunotherapy products.